PDF
FLIP
Cómo citar
Varela Villota, L. E., Trujillo Montalvo, E., Hidalgo Patiño, C., & Rocha Buelvas, A. (2016). Implementación de un programa de prevención de la tuberculosis en el departamento de Nariño, Colombia 2002-2012. Revista Investigaciones Andina, 18(32), 1551-1592. https://doi.org/10.33132/01248146.562
Formatos de citación
Resumen
Introducción. El objeto de este manuscrito es reflexionar sobre la experiencia de la implementación del programa de prevención de la tuberculosis en el departamento de Nariño en la última década, bajo la estrategia DOTS-TAES (Direct Observerd Treatment Short Course) y tratamiento acortado estrictamente supervisado de la OMS.
Metodología. Se realizó una reflexión a partir de documentos y experiencias
institucionales, y una revisión narrativa.
Resultados. La experiencia en el departamento de Nariño ha permitido reducir significativamente la incidencia de tuberculosis, dado el apoyo internacional y el énfasis en la prevención, mediante esquemas de atención primaria en salud. La intervención más relevante de este programa ha sido contar con un grupo exclusivo de atención a la tuberculosis y el seguimiento a los casos en cada municipio
Conclusión. El programa es novedoso porque difiere de otros, orientados al diagnóstico y tratamiento oportunista; es decir, cuando el paciente consulta enfermo.
Palabras clave:
Licencia
Los autores deben declarar la no existencia de conflictos de intereses ya sea por motivos de financiación del proyecto del cual es resultado el artículo; así como por motivos intelectuales, académicos, morales e investigativos.
La Revista de Investigaciones Andina se acoge a las normas éticas para publicaciones dadas por el COPE: http://publicationethics.org/resources/code-conduct
Citas
1. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. Geneva: WHO; 2005.
2. Organización Panamericana de la Salud (OPS). Organización Mundial de la Salud (OMS). Reunión regional de directores nacionales de programas de control de la tuberculosis: informe final. Ecuador: OAS & OMS; 1997.
3. World Health Organization (WHO). An expanded DOTS framework for effective tuberculosis control: stop TB communicable disease. Geneva: WHO; 2002.
4. Stop TB Partnership: TB/HIV working group. Guidelines for implementing collaborative TB and HIV programme activities. Geneva: WHO; 2003.
5. World Health Organization (WHO). Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: WHO; 2006.
6. World Health Organization (WHO). Treatment of tuberculosis: guidelines for national programmes. Third edition. Geneva: WHO; 2003.
7. World Health Organization (WHO). Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. Geneva: WHO; 2007.
8. World Health Organization (WHO). Guidelines for establishing DOTS-PLUS pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). Geneva: WHO; 2000.
9. Cobelens F, van Kampen S, Ochodo E, Atun R, Lienhardt C. Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review. PLoS Med 2012; 9(12): e1001358. http://dx.doi.org/10.1371/journal.pmed.1001358
10. González ER, Armas L. New Indicators Proposed to Assess Tuberculosis Control and Elimination in Cuba. MEDICC Review 2012, Vol 14, No 4: 40-43. http://dx.doi.org/10.1590/S1555-79602012000400009
11. Brasil. Manual de recomendacões para o controle da tuberculose no Brasil. Brasília: Ministério da Saúde, Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica; 2011.
12. Nogueira JdA, Ruffino-Netto A, Villa TCS, Monroe AA, Lucca MES: Implantação da estratégia DOTS no controle da tuberculose em Ribeirão Preto, São Paulo (1998-2004). Boletim de Pneumologia Sanitária 2006, 14(3): 141–144.
13. WHO Global report on TB 2011[Internet]. Available from: http://www.who.int/tb/Públications/global_report/en/ [Last cited in 2011 Oct 20].
14. Horsburgh CR., Rubin EJ. Latent Tuberculosis Infection in the United States N Engl J Med 2011; 364; 15: 1441-8.
15. Leite G. Research on tuberculosis: 75 years of IBIT contributions. Braz J Infect Dis. 2013; 1 7(2): 205–210.
16. Bezerra LC, Freese E, Frias PG, Samico I, Almeida CK. Epidemiological surveillance at the municipal level: evaluation of the degree of implementation. Cad Saude Pública 2009, 25(4):827–839. http://dx.doi.org/10.1590/S0102-311X2009000400014
17. Ramya Ananthakrishnan, Anita Jeyaraj1, Gopal Palani1, B. W. C. Sathiyasekaran. Socioeconomic impact of TB on patients registered within RNTCP and their families in the year 2007 in Chennai, India. Lung India 2012, 29 (3): 221-26. http://dx.doi.org/10.4103/0970-2113.99103
18. Lawn SD. Tuberculosis in Ghana: Social stigma and compliance with treatment. Int J Tuberc Lung Dis 2000; 4: 1190-2.
19. Munniyandi M, Rajeshwari R. Tuberculosis and poverty. ICMR Bull 2002:32 (3): 25-30.
20. Muniyandi, M, Rajeswari R, Balasubramanian R. Tuberculosis control programme - Is it pro poor. SAARC J Tuberc Lung Dis HIV/AIDS 2004; 1:14-9.
21. Booysen F le R, Bachmann M, Matebesi Z, Meyer. The socio-economic impact of HIV/AIDS on households in South Africa: Pilot study in Welkom and Qwaqwa, Free State province. J Final Report University of University of the Free State Centre for Health Systems Research and Development January 2004. Available from: http://www.sarpn.org/ documents/d0001489/P1822-Welkom-study_AIDS_January2004.pdf [Last cited in 2011 Oct 20].
22. González E, Armas L, Baly A, Gálvez A, Álvarez M, Ferrer G, et al. Impacto económico-social del programa de control de tuberculosis en la población cubana. Cad Saude Pública Río de Janeiro. 2000; 16(3):687–99. http://dx.doi.org/10.1590/S0102-311X2000000300017
23. Braga JU, Conceição DA, Trajman A. Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in brazil: an ecological study. BMC Public Health 2013, 13:321 http://dx.doi.org/10.1186/1471-2458-13-321
24. Felisberto E, Freese E, Natal S, Alves CKA. Contribuindo com a institucionalização da avaliação em saúde: uma proposta de auto-avaliação. Cad Saude Pública 2008; 24:1-12. http://dx.doi.org/10.1590/s0102-311x2008000900015
25. Organización Mundial de la Salud (OMS). Un marco ampliado de DOTS para el control eficaz de la Tuberculosis. Alianza Alto a la Tuberculosis. Enfermedades transmisibles. Ginebra: OMS; 2002.
26. World Health Organization (WHO). Compendium of indicators for monitoring and evaluating National Tuberculosis Programs. Geneva: WHO; 2009
27. Oliveira GP, Wieczorek Torrens A, Bartholomay P, Barreira D. Tuberculosis in Brazil: last ten years analysis – 2001–2010. Braz J Infect Dis. 2013, 17 (2): 218–233. http://dx.doi.org/10.1016/j.bjid.2013.01.005
28. Pan American Health Organization (PAHO). Regional Plan for Tuberculosis Control, 2006–2015. Washington, DC: PAHO; 2006.
29. Oliveira LG, Natal S, Felisberto E, Almeida Alves CK, Moreira E. Modelo de avaliação do programa de controle da tuberculose. Ciência & Saúde Coletiva 2010, 15(1):997-1008. http://dx.doi.org/10.1590/S1413-81232010000700006
30. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010; 16: 71–284. http://dx.doi.org/10.1097/mcp.0b013e328338094f
31. Mann G, Squire SB, Bissell K, Eliseev P, Du Toit E, et al. Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools. Int J Tuberc Lung Dis 2010; 14: 1518–1524.
2. Organización Panamericana de la Salud (OPS). Organización Mundial de la Salud (OMS). Reunión regional de directores nacionales de programas de control de la tuberculosis: informe final. Ecuador: OAS & OMS; 1997.
3. World Health Organization (WHO). An expanded DOTS framework for effective tuberculosis control: stop TB communicable disease. Geneva: WHO; 2002.
4. Stop TB Partnership: TB/HIV working group. Guidelines for implementing collaborative TB and HIV programme activities. Geneva: WHO; 2003.
5. World Health Organization (WHO). Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: WHO; 2006.
6. World Health Organization (WHO). Treatment of tuberculosis: guidelines for national programmes. Third edition. Geneva: WHO; 2003.
7. World Health Organization (WHO). Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. Geneva: WHO; 2007.
8. World Health Organization (WHO). Guidelines for establishing DOTS-PLUS pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). Geneva: WHO; 2000.
9. Cobelens F, van Kampen S, Ochodo E, Atun R, Lienhardt C. Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review. PLoS Med 2012; 9(12): e1001358. http://dx.doi.org/10.1371/journal.pmed.1001358
10. González ER, Armas L. New Indicators Proposed to Assess Tuberculosis Control and Elimination in Cuba. MEDICC Review 2012, Vol 14, No 4: 40-43. http://dx.doi.org/10.1590/S1555-79602012000400009
11. Brasil. Manual de recomendacões para o controle da tuberculose no Brasil. Brasília: Ministério da Saúde, Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica; 2011.
12. Nogueira JdA, Ruffino-Netto A, Villa TCS, Monroe AA, Lucca MES: Implantação da estratégia DOTS no controle da tuberculose em Ribeirão Preto, São Paulo (1998-2004). Boletim de Pneumologia Sanitária 2006, 14(3): 141–144.
13. WHO Global report on TB 2011[Internet]. Available from: http://www.who.int/tb/Públications/global_report/en/ [Last cited in 2011 Oct 20].
14. Horsburgh CR., Rubin EJ. Latent Tuberculosis Infection in the United States N Engl J Med 2011; 364; 15: 1441-8.
15. Leite G. Research on tuberculosis: 75 years of IBIT contributions. Braz J Infect Dis. 2013; 1 7(2): 205–210.
16. Bezerra LC, Freese E, Frias PG, Samico I, Almeida CK. Epidemiological surveillance at the municipal level: evaluation of the degree of implementation. Cad Saude Pública 2009, 25(4):827–839. http://dx.doi.org/10.1590/S0102-311X2009000400014
17. Ramya Ananthakrishnan, Anita Jeyaraj1, Gopal Palani1, B. W. C. Sathiyasekaran. Socioeconomic impact of TB on patients registered within RNTCP and their families in the year 2007 in Chennai, India. Lung India 2012, 29 (3): 221-26. http://dx.doi.org/10.4103/0970-2113.99103
18. Lawn SD. Tuberculosis in Ghana: Social stigma and compliance with treatment. Int J Tuberc Lung Dis 2000; 4: 1190-2.
19. Munniyandi M, Rajeshwari R. Tuberculosis and poverty. ICMR Bull 2002:32 (3): 25-30.
20. Muniyandi, M, Rajeswari R, Balasubramanian R. Tuberculosis control programme - Is it pro poor. SAARC J Tuberc Lung Dis HIV/AIDS 2004; 1:14-9.
21. Booysen F le R, Bachmann M, Matebesi Z, Meyer. The socio-economic impact of HIV/AIDS on households in South Africa: Pilot study in Welkom and Qwaqwa, Free State province. J Final Report University of University of the Free State Centre for Health Systems Research and Development January 2004. Available from: http://www.sarpn.org/ documents/d0001489/P1822-Welkom-study_AIDS_January2004.pdf [Last cited in 2011 Oct 20].
22. González E, Armas L, Baly A, Gálvez A, Álvarez M, Ferrer G, et al. Impacto económico-social del programa de control de tuberculosis en la población cubana. Cad Saude Pública Río de Janeiro. 2000; 16(3):687–99. http://dx.doi.org/10.1590/S0102-311X2000000300017
23. Braga JU, Conceição DA, Trajman A. Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in brazil: an ecological study. BMC Public Health 2013, 13:321 http://dx.doi.org/10.1186/1471-2458-13-321
24. Felisberto E, Freese E, Natal S, Alves CKA. Contribuindo com a institucionalização da avaliação em saúde: uma proposta de auto-avaliação. Cad Saude Pública 2008; 24:1-12. http://dx.doi.org/10.1590/s0102-311x2008000900015
25. Organización Mundial de la Salud (OMS). Un marco ampliado de DOTS para el control eficaz de la Tuberculosis. Alianza Alto a la Tuberculosis. Enfermedades transmisibles. Ginebra: OMS; 2002.
26. World Health Organization (WHO). Compendium of indicators for monitoring and evaluating National Tuberculosis Programs. Geneva: WHO; 2009
27. Oliveira GP, Wieczorek Torrens A, Bartholomay P, Barreira D. Tuberculosis in Brazil: last ten years analysis – 2001–2010. Braz J Infect Dis. 2013, 17 (2): 218–233. http://dx.doi.org/10.1016/j.bjid.2013.01.005
28. Pan American Health Organization (PAHO). Regional Plan for Tuberculosis Control, 2006–2015. Washington, DC: PAHO; 2006.
29. Oliveira LG, Natal S, Felisberto E, Almeida Alves CK, Moreira E. Modelo de avaliação do programa de controle da tuberculose. Ciência & Saúde Coletiva 2010, 15(1):997-1008. http://dx.doi.org/10.1590/S1413-81232010000700006
30. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010; 16: 71–284. http://dx.doi.org/10.1097/mcp.0b013e328338094f
31. Mann G, Squire SB, Bissell K, Eliseev P, Du Toit E, et al. Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools. Int J Tuberc Lung Dis 2010; 14: 1518–1524.
Descargas
La descarga de datos todavía no está disponible.
